Global Information
회사소개 | 문의 | 비교리스트

세계의 크레아티닌 어세이 시장 : 예측과 기회(-2025년)

Global Creatinine Assay Market By Disease, By Method,By Kit, By Sample (Serum, Urine, Cerebrospinal fluid, Others), By End-User, By Company, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 938723
페이지 정보 영문 114 Pages
가격
US $ 4,450 ₩ 5,094,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,239,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,819,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 크레아티닌 어세이 시장 : 예측과 기회(-2025년) Global Creatinine Assay Market By Disease, By Method,By Kit, By Sample (Serum, Urine, Cerebrospinal fluid, Others), By End-User, By Company, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 114 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

크레아티닌은 근육에 의해 생성되는 노폐물의 일종입니다. 근육 대사의 결과로서 생성되며 소변으로부터 배출됩니다. 크레아티닌 어세이는 체내에 존재하는 크레아티닌의 레벨과 신장의 건강 상태를 나타냅니다. 세계의 크레아티닌 어세이(Creatinine Assay) 시장은 만성신장 질환 및 기타 신장 장애를 앓고 있는 환자의 증가에 수반하는 신장 기능 검사의 기술 진보와 혁신에 의해 추진되고 있습니다.

세계의 크레아티닌 어세이 시장을 부문별 및 지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 촉진요인과 과제, 시장 동향, 경쟁 구도, 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 크레아티닌 어세이 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 질환별(1형 당뇨병, 2형 당뇨병, 신장병, 기타)
    • 방법별(O'Leary modified Jaffe assay, Jaffe, 효소 시험)
    • 키트별(크레아티닌 pap 테스트 키트, ELISA 테스트 키트, Kinetic Jaffe법에 따르는 키트, 크레아티닌 비색법/형광법 어세이 키트)
    • 샘플별(혈청, 소변, 뇌척수액(CSF), 기타)
    • 최종사용자별(병원·클리닉, 진단 연구소, 기타)
    • 기업별(2019)
    • 지역별
  • 시장의 매력 지수

제6장 아시아태평양의 크레아티닌 어세이 시장 전망

  • 시장 규모와 예측 >
  • 시장 점유율과 예측
    • 질환별
    • 방법별
    • 키트별
    • 샘플별
    • 최종사용자별
    • 국가별
  • 시장의 매력 지수
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 싱가포르
    • 호주

제7장 유럽의 크레아티닌 어세이 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 질환별
    • 방법별
    • 키트별
    • 샘플별
    • 최종사용자별
    • 국가별
  • 시장의 매력 지수
  • 유럽 : 국가 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아

제8장 북미의 크레아티닌 어세이 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 질환별
    • 방법별
    • 키트별
    • 샘플별
    • 최종사용자별
    • 국가별
  • 시장의 매력 지수
  • 북미 : 국가 분석
    • 미국
    • 멕시코
    • 캐나다

제9장 남아메리카의 크레아티닌 어세이 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 질환별
    • 방법별
    • 키트별
    • 샘플별
    • 최종사용자별
    • 국가별
  • 시장의 매력 지수
  • 남미 : 국가 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동과 아프리카의 크레아티닌 어세이 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 질환별
    • 방법별
    • 키트별
    • 샘플별
    • 최종사용자별
    • 국가별
  • 시장의 매력 지수
  • 중동·아프리카 : 국가 분석
    • 남아프리카공화국
    • 사우디아라비아
    • UAE

제11장 시장 역학

  • 촉진요인
  • 억제요인

제12장 시장 동향과 개발

제13장 경쟁 구도

  • 경쟁 전망
  • 기업 개요
    • BioVision
    • Thermo Fisher Scientific
    • Merck
    • Bioassay Systems
    • Cell Biolabs
    • Fujifilm
    • Quidel Corporation
    • Enzo Life Sciences
    • Tulip Diagnostics
    • Genway Biotech
    • Crystal Chem
    • Randox Laboratories
    • Nova Biomedical
    • Cayman Chemical
    • Pfizer
    • DiaSys Diagnostic Systems
    • Abbexa
    • MedTest DX
    • Roche
    • Abcam

제14장 전략적 권장사항

제15장 면책사항

KSA 20.06.11

Creatinine is a kind of waste product produced by the muscles. It is produced as a result of muscle metabolism and is eliminated through the urine. Sometimes, creatinine is produced due to excessive consumption of meat, especially red meat. A creatinine assay indicates the level of creatinine present in the body and the status of the kidney health.

Generally, the level of creatinine varies from 0.5 to 1.2 milligrams (mg) per deciliter (dL). The level of creatinine varies in male and female and is generally high in males. The normal range of creatinine in the blood are approximately 0.6 to 1.2 milligrams (mg) per deciliter (dL) in adult males and 0.5 to 1.1 milligrams per deciliter in adult females. Beyond this range, any value is indictive of poor glomerular filtration rate and kidney impairment.

Global creatinine assay market is expected to grow at a formidable rate during the forecast period. The global creatinine assay market is driven by the technological advancements and innovations in the field of kidney function testing on account of the growing number of patients suffering from chronic kidney disease or other renal impairments. Additionally, growing awareness among the population pertaining to adoption of preventive healthcare is further expected to propel the market during forecast years. Furthermore, supportive government initiatives & policies for promoting renal health awareness is anticipated to foster the growth over 2025.

The global creatinine assay market can be segmented based on disease, method, kit, sample, end user, company and region. Based on disease, the market can be categorized into type 1 diabetes, type 2 diabetes, kidney disease and others. The kidney disease segment is expected to dominate the market during the forecast period. This can be accredited to the increasing prevalence of renal diseases. Additionally, creatinine assay is majorly and more frequently done in kidney disease as compared to diabetes wherein creatinine assay is generally done once or twice a year depending upon the condition. While, in case of any renal disease, the creatinine assay is done on a regular basis.

Regionally, the creatinine assay market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the market during forecast period. This can be attributed to the presence of a large geriatric population base in the country. Additionally, the presence of key players in the region is further expected to propel the market through 2025.

Major players operating in the global creatinine assay market include BioVision, Thermo Fisher Scientific, Merck, Bioassay Systems, Cell Biolabs, Fujifilm, Quidel Corporation, Enzo Life Sciences, Tulip Diagnostics, Genway Biotech, Crystal Chem, Randox Laboratories, Nova Biomedical, Cayman Chemical, Pfizer, DiaSys Diagnostic Systems, Abbexa, MedTest DX, Roche, Abcam and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of global creatinine assay market.
  • To classify and forecast global creatinine assay market based on disease, method, kit, sample, end user, company and regional distribution.
  • To identify drivers and challenges for global creatinine assay market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global creatinine assay market.
  • To identify and analyze the profile of leading players operating in global creatinine assay market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global creatinine assay market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Creatinine assay kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to creatinine assay
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global creatinine assay market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Disease:

Type 1 Diabetes

Type 2 Diabetes

Kidney disease

Others

  • Market, By Method:

O'Leary modified Jaffe assay

Jaffe

Enzymatic

  • Market, By Kit:

Creatinine-pap test kits

ELISA test kits

Jaffe's kinetic test kits

Creatinine Colorimetric/Fluorometric Assay Kit

  • Market, By Sample:

Serum

Urine

Cerebrospinal fluid (CSF)

Others

  • Market, By End User:

Hospitals and clinics

Diagnostic laboratories

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global creatinine assay market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Creatinine Assay Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease, Others)
    • 5.2.2. By Method (O'Leary modified Jaffe assay, Jaffe, Enzymatic)
    • 5.2.3. By Kit (Creatinine-pap test kits, ELISA test kits, Jaffe's kinetic test kits, Creatinine Colorimetric/Fluorometric Assay Kit)
    • 5.2.4. By Sample (Serum, Urine, Cerebrospinal fluid (CSF), Others)
    • 5.2.5. By End-User (Hospitals and clinics, Diagnostic laboratories, Others)
    • 5.2.6. By Company (2019)
    • 5.2.7. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Creatinine Assay Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Disease
    • 6.2.2. By Method
    • 6.2.3. By Kit
    • 6.2.4. By Sample
    • 6.2.5. By End-User
    • 6.2.6. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Creatinine Assay Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Disease
        • 6.4.1.2.2. By Method
        • 6.4.1.2.3. By Kit
        • 6.4.1.2.4. By Sample
        • 6.4.1.2.5. By End-User
    • 6.4.2. India Creatinine Assay Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Disease
        • 6.4.2.2.2. By Method
        • 6.4.2.2.3. By Kit
        • 6.4.2.2.4. By Sample
        • 6.4.2.2.5. By End-User
    • 6.4.3. Japan Creatinine Assay Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Disease
        • 6.4.3.2.2. By Method
        • 6.4.3.2.3. By Kit
        • 6.4.3.2.4. By Sample
        • 6.4.3.2.5. By End-User
    • 6.4.4. South Korea Creatinine Assay Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Disease
        • 6.4.4.2.2. By Method
        • 6.4.4.2.3. By Kit
        • 6.4.4.2.4. By Sample
        • 6.4.4.2.5. By End-User
    • 6.4.5. Singapore Creatinine Assay Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Disease
        • 6.4.5.2.2. By Method
        • 6.4.5.2.3. By Kit
        • 6.4.5.2.4. By Sample
        • 6.4.5.2.5. By End-User
    • 6.4.6. Australia Creatinine Assay Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Disease
        • 6.4.6.2.2. By Method
        • 6.4.6.2.3. By Kit
        • 6.4.6.2.4. By Sample
        • 6.4.6.2.5. By End-User

7. Europe Creatinine Assay Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Disease
    • 7.2.2. By Method
    • 7.2.3. By Kit
    • 7.2.4. By Sample
    • 7.2.5. By End-User
    • 7.2.6. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Creatinine Assay Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Disease
        • 7.4.1.2.2. By Method
        • 7.4.1.2.3. By Kit
        • 7.4.1.2.4. By Sample
        • 7.4.1.2.5. By End-User
    • 7.4.2. Germany Creatinine Assay Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Disease
        • 7.4.2.2.2. By Method
        • 7.4.2.2.3. By Kit
        • 7.4.2.2.4. By Sample
        • 7.4.2.2.5. By End-User
    • 7.4.3. United Kingdom Creatinine Assay Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Disease
        • 7.4.3.2.2. By Method
        • 7.4.3.2.3. By Kit
        • 7.4.3.2.4. By Sample
        • 7.4.3.2.5. By End-User
    • 7.4.4. Italy Creatinine Assay Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Disease
        • 7.4.4.2.2. By Method
        • 7.4.4.2.3. By Kit
        • 7.4.4.2.4. By Sample
        • 7.4.4.2.5. By End-User

8. North America Creatinine Assay Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Disease
    • 8.2.2. By Method
    • 8.2.3. By Kit
    • 8.2.4. By Sample
    • 8.2.5. By End-User
    • 8.2.6. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. North America: Country Analysis
    • 8.4.1. United States Creatinine Assay Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Disease
        • 8.4.1.2.2. By Method
        • 8.4.1.2.3. By Kit
        • 8.4.1.2.4. By Sample
        • 8.4.1.2.5. By End-User
    • 8.4.2. Mexico Creatinine Assay Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Disease
        • 8.4.2.2.2. By Method
        • 8.4.2.2.3. By Kit
        • 8.4.2.2.4. By Sample
        • 8.4.2.2.5. By End-User
    • 8.4.3. Canada Creatinine Assay Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Disease
        • 8.4.3.2.2. By Method
        • 8.4.3.2.3. By Kit
        • 8.4.3.2.4. By Sample
        • 8.4.3.2.5. By End-User

9. South America Creatinine Assay Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Disease
    • 9.2.2. By Method
    • 9.2.3. By Kit
    • 9.2.4. By Sample
    • 9.2.5. By End-User
    • 9.2.6. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Creatinine Assay Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Disease
        • 9.4.1.2.2. By Method
        • 9.4.1.2.3. By Kit
        • 9.4.1.2.4. By Sample
        • 9.4.1.2.5. By End-User
    • 9.4.2. Argentina Creatinine Assay Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Disease
        • 9.4.2.2.2. By Method
        • 9.4.2.2.3. By Kit
        • 9.4.2.2.4. By Sample
        • 9.4.2.2.5. By End-User
    • 9.4.3. Colombia Creatinine Assay Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Disease
        • 9.4.3.2.2. By Method
        • 9.4.3.2.3. By Kit
        • 9.4.3.2.4. By Sample
        • 9.4.3.2.5. By End-User

10. Middle East and Africa Creatinine Assay Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Disease
    • 10.2.2. By Method
    • 10.2.3. By Kit
    • 10.2.4. By Sample
    • 10.2.5. By End-User
    • 10.2.6. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Creatinine Assay Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Disease
        • 10.4.1.2.2. By Method
        • 10.4.1.2.3. By Kit
        • 10.4.1.2.4. By Sample
        • 10.4.1.2.5. By End-User
    • 10.4.2. Saudi Arabia Creatinine Assay Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Disease
        • 10.4.2.2.2. By Method
        • 10.4.2.2.3. By Kit
        • 10.4.2.2.4. By Sample
        • 10.4.2.2.5. By End-User
    • 10.4.3. UAE Creatinine Assay Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Disease
        • 10.4.3.2.2. By Method
        • 10.4.3.2.3. By Kit
        • 10.4.3.2.4. By Sample
        • 10.4.3.2.5. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Players Profiled (Leading Companies)
    • 13.2.1. BioVision
    • 13.2.2. Thermo Fisher Scientific
    • 13.2.3. Merck
    • 13.2.4. Bioassay Systems
    • 13.2.5. Cell Biolabs
    • 13.2.6. Fujifilm
    • 13.2.7. Quidel Corporation
    • 13.2.8. Enzo Life Sciences
    • 13.2.9. Tulip Diagnostics
    • 13.2.10. Genway Biotech
    • 13.2.11. Crystal Chem
    • 13.2.12. Randox Laboratories
    • 13.2.13. Nova Biomedical
    • 13.2.14. Cayman Chemical
    • 13.2.15. Pfizer
    • 13.2.16. DiaSys Diagnostic Systems
    • 13.2.17. Abbexa
    • 13.2.18. MedTest DX
    • 13.2.19. Roche
    • 13.2.20. Abcam

14. Strategic Recommendations

15. About Us & Disclaimer

Back to Top
전화 문의
F A Q